Complete CDMO Aspire Health Science operates as a clinical-stage CDMO for cell therapy, offering end-to-end manufacturing, development, and quality management in an FDA-registered facility in Orlando, enabling clients from research to clinical production.

Global Trial Support With existing manufacturing and trials in the United States, Canada, and the Bahamas, AHS is positioned to support multi-country clinical programs, offering cross-border regulatory familiarity and scalable production for diverse markets.

Outsourcing Ready As a smaller organization, AHS can be an agile partner for biotech companies seeking scalable cell therapy manufacturing, with opportunities to upsell process development, technology transfer, and product quality management.

Quality and Compliance The FDA-registered facility and cGMP capabilities provide a competitive advantage for clients requiring compliant, auditable manufacturing with robust QC/QA, regulatory readiness, and product release processes.

Collaborative Partnerships AHS has demonstrated collaboration through ACP-01 Midpoint Analysis with Hemostemix, suggesting opportunities to offer translational analytics, data management, and joint development partnerships to biotech and research organizations.